SBI Okasan Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.73M Buy
1,406
+100
+8% +$102K 0.06% 64
2026
Q1
$1.16M Sell
1,306
-417
-24% -$423K 0.05% 90
2025
Q4
$1.86M Buy
+1,723
New +$1.65M 0.1% 45

Other funds holding LLY

SBI Okasan Asset Management's LLY Position: Q2 2026 in Review

SBI Okasan Asset Management increased its Eli Lilly (LLY) stake by 7.7% in Q2 2026, buying an estimated $102K and bringing the position to 1,406 shares worth $1.73M. The position accounts for 0.06% of the portfolio, ranked #64.

SBI Okasan Asset Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.86M in Q4 2025. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • SBI Okasan Asset Management held 1,406 shares of Eli Lilly worth $1.73M as of Q2 2026.
  • SBI Okasan Asset Management bought 100 Eli Lilly shares in Q2 2026, an estimated $102K.
  • Eli Lilly made up 0.06% of SBI Okasan Asset Management's portfolio in Q2 2026, its #64 holding.
  • SBI Okasan Asset Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • SBI Okasan Asset Management's Eli Lilly position peaked at $1.86M in Q4 2025.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on SBI Okasan Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.